Remi Quirion - Publications

McGill University, Montreal, QC, Canada 

170 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mitazaki S, Nakagawasai O, Onogi H, Watanabe K, Takahashi K, Tan-No K, Quirion R, Srivastava LK, Tadano T. Role of prefrontal cortical 5-HT receptors and serotonin transporter in the behavioral deficits in post-pubertal rats following neonatal lesion of the ventral hippocampus. Behavioural Brain Research. 112226. PMID 31521737 DOI: 10.1016/j.bbr.2019.112226  0.56
2018 Castonguay D, Dufort-Gervais J, Ménard C, Chatterjee M, Quirion R, Bontempi B, Schneider JS, Arnsten AFT, Nairn AC, Norris CM, Ferland G, Bézard E, Gaudreau P, Lombroso PJ, Brouillette J. The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline. Current Biology : Cb. PMID 29576474 DOI: 10.1016/j.cub.2018.02.047  0.68
2016 Mahar I, Albuquerque MS, Mondragon-Rodriguez S, Cavanagh C, Davoli MA, Chabot JG, Williams S, Mechawar N, Quirion R, Krantic S. Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer's Disease. Frontiers in Aging Neuroscience. 8: 327. PMID 28154533 DOI: 10.3389/fnagi.2016.00327  0.68
2016 Liao R, Yan F, Zeng Z, Farhan M, Little P, Quirion R, Srivastava LK, Zheng W. Amiodarone-Induced Retinal Neuronal Cell Apoptosis Attenuated by IGF-1 via Counter Regulation of the PI3k/Akt/FoxO3a Pathway. Molecular Neurobiology. PMID 27774572 DOI: 10.1007/s12035-016-0211-x  0.56
2016 Cavanagh C, Tse YC, Nguyen HB, Krantic S, Breitner JC, Quirion R, Wong TP. Inhibiting tumor necrosis factor-α before amyloidosis prevents synaptic deficits in an Alzheimer's disease model. Neurobiology of Aging. 47: 41-49. PMID 27552480 DOI: 10.1016/j.neurobiolaging.2016.07.009  1
2016 Zeng Z, Wang X, Bhardwaj SK, Zhou X, Little PJ, Quirion R, Srivastava LK, Zheng W. The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt/FoxO3a Signaling Pathway. Molecular Neurobiology. PMID 27173157 DOI: 10.1007/s12035-016-9904-4  1
2016 Bouvier DS, Jones EV, Quesseveur G, Davoli MA, A Ferreira T, Quirion R, Mechawar N, Murai KK. High Resolution Dissection of Reactive Glial Nets in Alzheimer's Disease. Scientific Reports. 6: 24544. PMID 27090093 DOI: 10.1038/srep24544  0.68
2015 Zeng Z, Wang H, Shang F, Zhou L, Little PJ, Quirion R, Zheng W. Lithium ions attenuate serum-deprivation-induced apoptosis in PC12 cells through regulation of the Akt/FoxO1 signaling pathways. Psychopharmacology. PMID 26626328 DOI: 10.1007/s00213-015-4168-7  1
2015 Wang H, Quirion R, Little PJ, Cheng Y, Feng ZP, Sun HS, Xu J, Zheng W. Forkhead Box O Transcription Factors as Possible Mediators in the Development of Major Depression. Neuropharmacology. PMID 26279492 DOI: 10.1016/j.neuropharm.2015.08.020  1
2015 Colby-Milley J, Cavanagh C, Jego S, Breitner JC, Quirion R, Adamantidis A. Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages. Plos One. 10: e0130177. PMID 26076358 DOI: 10.1371/journal.pone.0130177  1
2015 Dumont Y, Bastianetto S, Duranton A, Breton L, Quirion R. Immunohistochemical distribution of neuropeptide Y, peptide YY, pancreatic polypeptide-like immunoreactivity and their receptors in the epidermal skin of healthy women. Peptides. 70: 7-16. PMID 26002416 DOI: 10.1016/j.peptides.2015.05.002  0.56
2015 Ménard C, Gaudreau P, Quirion R. Signaling pathways relevant to cognition-enhancing drug targets. Handbook of Experimental Pharmacology. 228: 59-98. PMID 25977080 DOI: 10.1007/978-3-319-16522-6_3  0.68
2015 Albuquerque MS, Mahar I, Davoli MA, Chabot JG, Mechawar N, Quirion R, Krantic S. Regional and sub-regional differences in hippocampal GABAergic neuronal vulnerability in the TgCRND8 mouse model of Alzheimer's disease. Frontiers in Aging Neuroscience. 7: 30. PMID 25852545 DOI: 10.3389/fnagi.2015.00030  1
2015 Ménard C, Quirion R, Vigneault E, Bouchard S, Ferland G, El Mestikawy S, Gaudreau P. Glutamate presynaptic vesicular transporter and postsynaptic receptor levels correlate with spatial memory status in aging rat models. Neurobiology of Aging. 36: 1471-82. PMID 25556161 DOI: 10.1016/j.neurobiolaging.2014.11.013  1
2015 Phillips AG, Hongaard-Andersen P, Moscicki RA, Sahakian B, Quirion R, Krishnan KR, Race T. Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25542690 DOI: 10.1093/ijnp/pyu100  1
2015 Bastianetto S, Ménard C, Quirion R. Neuroprotective action of resveratrol. Biochimica Et Biophysica Acta. 1852: 1195-1201. PMID 25281824 DOI: 10.1016/j.bbadis.2014.09.011  0.36
2014 Dumont Y, Quirion R. Neuropeptide Y pathways in anxiety-related disorders. Biological Psychiatry. 76: 834-5. PMID 25439997 DOI: 10.1016/j.biopsych.2014.09.015  0.56
2014 Andersen PH, Moscicki R, Sahakian B, Quirion R, Krishnan R, Race T, Phillips A. Securing the future of drug discovery for central nervous system disorders. Nature Reviews. Drug Discovery. 13: 871-2. PMID 25435203 DOI: 10.1038/nrd4489  1
2014 Yu W, Bonnet M, Farso M, Ma K, Chabot JG, Martin E, Torriglia A, Guan Z, McLaurin J, Quirion R, Krantic S. The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer's disease. Bmc Neuroscience. 15: 73. PMID 24915960 DOI: 10.1186/1471-2202-15-73  1
2014 Ménard C, Quirion R, Bouchard S, Ferland G, Gaudreau P. Glutamatergic signaling and low prodynorphin expression are associated with intact memory and reduced anxiety in rat models of healthy aging. Frontiers in Aging Neuroscience. 6: 81. PMID 24847259 DOI: 10.3389/fnagi.2014.00081  0.68
2014 Ménard C, Herzog H, Schwarzer C, Quirion R. Possible role of dynorphins in Alzheimer's disease and age-related cognitive deficits. Neuro-Degenerative Diseases. 13: 82-5. PMID 23970097 DOI: 10.1159/000353848  1
2013 Menard C, Bastianetto S, Quirion R. Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma. Frontiers in Cellular Neuroscience. 7: 281. PMID 24421757 DOI: 10.3389/fncel.2013.00281  1
2013 Ménard C, Tse YC, Cavanagh C, Chabot JG, Herzog H, Schwarzer C, Wong TP, Quirion R. Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 12792-804. PMID 23904614 DOI: 10.1523/JNEUROSCI.0290-13.2013  1
2013 Shukla M, Quirion R, Ma W. Reduced expression of pain mediators and pain sensitivity in amyloid precursor protein over-expressing CRND8 transgenic mice. Neuroscience. 250: 92-101. PMID 23850592 DOI: 10.1016/j.neuroscience.2013.06.064  1
2013 Goutagny R, Gu N, Cavanagh C, Jackson J, Chabot JG, Quirion R, Krantic S, Williams S. Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. The European Journal of Neuroscience. 37: 1896-902. PMID 23773058 DOI: 10.1111/ejn.12233  0.68
2013 Cavanagh C, Colby-Milley J, Bouvier D, Farso M, Chabot JG, Quirion R, Krantic S. βCTF-correlated burst of hippocampal TNFα occurs at a very early, pre-plaque stage in the TgCRND8 mouse model of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 36: 233-8. PMID 23579326 DOI: 10.3233/JAD-122131  0.68
2013 Veyrat-Durebex C, Quirion R, Ferland G, Dumont Y, Gaudreau P. Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. Neuropeptides. 47: 163-9. PMID 23410741 DOI: 10.1016/j.npep.2013.01.001  0.68
2013 Morales-Medina JC, Juarez I, Venancio-García E, Cabrera SN, Menard C, Yu W, Flores G, Mechawar N, Quirion R. Impaired structural hippocampal plasticity is associated with emotional and memory deficits in the olfactory bulbectomized rat. Neuroscience. 236: 233-43. PMID 23357118 DOI: 10.1016/j.neuroscience.2013.01.037  1
2013 Ito M, Dumont Y, Quirion R. Mood and memory-associated behaviors in neuropeptide Y5 knockout mice. Neuropeptides. 47: 75-84. PMID 23218957 DOI: 10.1016/j.npep.2012.10.009  0.56
2013 Wang D, Ruan L, Hong Y, Chabot JG, Quirion R. Involvement of PKA-dependent upregulation of nNOS-CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats. Experimental Neurology. 239: 111-9. PMID 23063906 DOI: 10.1016/j.expneurol.2012.10.006  0.68
2012 Morales-Medina JC, Dumont Y, Bonaventure P, Quirion R. Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat. Neuropeptides. 46: 329-34. PMID 23103057 DOI: 10.1016/j.npep.2012.09.009  0.64
2012 Zheng W, Wang H, Zeng Z, Lin J, Little PJ, Srivastava LK, Quirion R. The possible role of the Akt signaling pathway in schizophrenia. Brain Research. 1470: 145-58. PMID 22771711 DOI: 10.1016/j.brainres.2012.06.032  0.56
2012 Morales-Medina JC, Dominguez-Lopez S, Gobbi G, Beck-Sickinger AG, Quirion R. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat. Behavioural Brain Research. 233: 298-304. PMID 22613731 DOI: 10.1016/j.bbr.2012.05.015  1
2012 Efthimiadi L, Farso M, Quirion R, Krantic S. Cyclin D1 induction preceding neuronal death via the excitotoxic NMDA pathway involves selective stimulation of extrasynaptic NMDA receptors and JNK pathway. Neuro-Degenerative Diseases. 10: 80-91. PMID 22354185 DOI: 10.1159/000335911  0.68
2012 Krantic S, Isorce N, Mechawar N, Davoli MA, Vignault E, Albuquerque M, Chabot JG, Moyse E, Chauvin JP, Aubert I, McLaurin J, Quirion R. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. Journal of Alzheimer's Disease : Jad. 29: 293-308. PMID 22232004 DOI: 10.3233/JAD-2011-110830  1
2012 Bringas ME, Morales-Medina JC, Flores-Vivaldo Y, Negrete-Diaz JV, Aguilar-Alonso P, León-Chávez BA, Lazcano-Ortiz Z, Monroy E, Rodríguez-Moreno A, Quirion R, Flores G. Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat. Neuropharmacology. 62: 1848-57. PMID 22207157 DOI: 10.1016/j.neuropharm.2011.12.008  1
2012 Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neuropharmacology. 62: 200-8. PMID 21803058 DOI: 10.1016/j.neuropharm.2011.06.030  1
2011 Wang Z, Chabot JG, Quirion R. On the possible role of ERK, p38 and CaMKII in the regulation of CGRP expression in morphine-tolerant rats. Molecular Pain. 7: 68. PMID 21933441 DOI: 10.1186/1744-8069-7-68  0.68
2011 Yu W, Mechawar N, Krantic S, Quirion R. α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. Journal of Neurochemistry. 119: 848-58. PMID 21884524 DOI: 10.1111/j.1471-4159.2011.07466.x  0.68
2011 Farso MC, Krantic S, Rubio M, Sarfati M, Quirion R. The retinoid, 6-[3-adamantyl-4-hydroxyphenyl]-2-napthalene carboxylic acid, controls proliferative, morphological, and inflammatory responses involved in microglial activation without cytotoxic effects. Neuroscience. 192: 172-84. PMID 21749910 DOI: 10.1016/j.neuroscience.2011.06.053  1
2011 Bastianetto S, Krantic S, Chabot JG, Quirion R. Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols. Current Alzheimer Research. 8: 445-51. PMID 21605053  0.68
2011 Pasic MD, Diamandis EP, McLaurin J, Holtzman DM, Schmitt-Ulms G, Quirion R. Alzheimer disease: advances in pathogenesis, diagnosis, and therapy. Clinical Chemistry. 57: 664-9. PMID 21310870 DOI: 10.1373/clinchem.2011.161828  1
2011 Benoit CE, Rowe WB, Menard C, Sarret P, Quirion R. Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory. Trends in Pharmacological Sciences. 32: 43-52. PMID 21129790 DOI: 10.1016/  1
2011 Yu W, Gubkina O, Mechawar N, Elwell D, Quirion R, Krantic S. Expression of apoptosis-inducing factor (AIF) in the aged rat brain. Neurobiology of Aging. 32: 179-80. PMID 19251341 DOI: 10.1016/j.neurobiolaging.2009.01.010  0.68
2010 Bastianetto S, Dumont Y, Duranton A, Vercauteren F, Breton L, Quirion R. Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. Plos One. 5: e12935. PMID 20886076 DOI: 10.1371/journal.pone.0012935  0.56
2010 Benoit CE, Bastianetto S, Brouillette J, Tse Y, Boutin JA, Delagrange P, Wong T, Sarret P, Quirion R. Loss of quinone reductase 2 function selectively facilitates learning behaviors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 12690-700. PMID 20861374 DOI: 10.1523/JNEUROSCI.2808-10.2010  1
2010 Hong Y, Wang D, Chabot JG, Ma W, Chen P, Quirion R. A role for protein kinase C-dependent upregulation of adrenomedullin in the development of morphine tolerance in male rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 12508-16. PMID 20844145 DOI: 10.1523/JNEUROSCI.0306-10.2010  0.68
2010 Wang Z, Ma W, Chabot JG, Quirion R. Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance. Peptides. 31: 2179-84. PMID 20804799 DOI: 10.1016/j.peptides.2010.08.020  0.68
2010 Wang Z, Ma W, Chabot JG, Quirion R. Calcitonin gene-related peptide as a regulator of neuronal CaMKII-CREB, microglial p38-NFκB and astroglial ERK-Stat1/3 cascades mediating the development of tolerance to morphine-induced analgesia. Pain. 151: 194-205. PMID 20691540 DOI: 10.1016/j.pain.2010.07.006  0.68
2010 Bastianetto S, Quirion R. Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Experimental Neurology. 225: 237-9. PMID 20603117 DOI: 10.1016/j.expneurol.2010.06.019  0.36
2010 Schorscher-Petcu A, Sotocinal S, Ciura S, Dupré A, Ritchie J, Sorge RE, Crawley JN, Hu SB, Nishimori K, Young LJ, Tribollet E, Quirion R, Mogil JS. Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8274-84. PMID 20554879 DOI: 10.1523/JNEUROSCI.1594-10.2010  1
2010 Bastiat G, Plourde F, Motulsky A, Furtos A, Dumont Y, Quirion R, Fuhrmann G, Leroux JC. Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease. Biomaterials. 31: 6031-8. PMID 20472283 DOI: 10.1016/j.biomaterials.2010.04.009  0.56
2010 Yu W, Mechawar N, Krantic S, Quirion R. Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. The American Journal of Pathology. 176: 2209-18. PMID 20228227 DOI: 10.2353/ajpath.2010.090496  0.68
2010 Doggui S, Brouillette J, Chabot JG, Farso M, Quirion R. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8). Neuro-Degenerative Diseases. 7: 88-95. PMID 20173334 DOI: 10.1159/000285513  0.68
2010 Ma W, Dumont Y, Vercauteren F, Quirion R. Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology. 130: 399-409. PMID 20141542 DOI: 10.1111/j.1365-2567.2009.03239.x  0.56
2010 Mahaut S, Dumont Y, Fournier A, Quirion R, Moyse E. Neuropeptide Y receptor subtypes in the dorsal vagal complex under acute feeding adaptation in the adult rat. Neuropeptides. 44: 77-86. PMID 19880180 DOI: 10.1016/j.npep.2009.10.001  0.56
2010 Morales-Medina JC, Dumont Y, Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Research. 1314: 194-205. PMID 19782662 DOI: 10.1016/j.brainres.2009.09.077  0.64
2010 Ma W, Chabot JG, Vercauteren F, Quirion R. Injured nerve-derived COX2/PGE2 contributes to the maintenance of neuropathic pain in aged rats. Neurobiology of Aging. 31: 1227-37. PMID 18786748 DOI: 10.1016/j.neurobiolaging.2008.08.002  0.68
2009 Hong Y, Liu Y, Chabot JG, Fournier A, Quirion R. Upregulation of adrenomedullin in the spinal cord and dorsal root ganglia in the early phase of CFA-induced inflammation in rats. Pain. 146: 105-13. PMID 19683388 DOI: 10.1016/j.pain.2009.07.015  0.68
2009 Tong XK, Nicolakakis N, Fernandes P, Ongali B, Brouillette J, Quirion R, Hamel E. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiology of Disease. 35: 406-14. PMID 19524673 DOI: 10.1016/j.nbd.2009.06.003  1
2009 Morales-Medina JC, Sanchez F, Flores G, Dumont Y, Quirion R. Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. Journal of Chemical Neuroanatomy. 38: 266-72. PMID 19505571 DOI: 10.1016/j.jchemneu.2009.05.009  1
2009 Schorscher-Petcu A, Austin JS, Mogil JS, Quirion R. Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity. Journal of Molecular Neuroscience : Mn. 39: 125-36. PMID 19381879 DOI: 10.1007/s12031-009-9201-z  1
2009 Wang Z, Ma W, Chabot JG, Quirion R. Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 2576-86. PMID 19299480 DOI: 10.1096/fj.08-128348  0.68
2009 Rajah MN, Bastianetto S, Bromley-Brits K, Cools R, D'Esposito M, Grady CL, Poirier J, Quirion R, Raz N, Rogaeva E, Song W, Pruessner J. Biological changes associated with healthy versus pathological aging: a symposium review. Ageing Research Reviews. 8: 140-6. PMID 19274854 DOI: 10.1016/j.arr.2009.01.003  1
2009 Bastianetto S, Dumont Y, Han Y, Quirion R. Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site? Cns Neuroscience & Therapeutics. 15: 76-83. PMID 19228181 DOI: 10.1111/j.1755-5949.2008.00074.x  0.56
2009 Ernst C, Deleva V, Deng X, Sequeira A, Pomarenski A, Klempan T, Ernst N, Quirion R, Gratton A, Szyf M, Turecki G. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Archives of General Psychiatry. 66: 22-32. PMID 19124685 DOI: 10.1001/archpsyc.66.1.22  1
2008 Morales-Medina JC, Mejorada A, Romero-Curiel A, Aguilar-Alonso P, León-Chávez BA, Gamboa C, Quirion R, Flores G. Neonatal administration of N-omega-nitro-L-arginine induces permanent decrease in NO levels and hyperresponsiveness to locomotor activity by D-amphetamine in postpubertal rats. Neuropharmacology. 55: 1313-20. PMID 18790702 DOI: 10.1016/j.neuropharm.2008.08.019  1
2008 Bastianetto S, Krantic S, Quirion R. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. Mini Reviews in Medicinal Chemistry. 8: 429-35. PMID 18473932  0.68
2008 Owji AA, Chabot JG, Dumont Y, Quirion R. Adrenomedullin-2/intermedin induces cAMP accumulation in dissociated rat spinal cord cells: evidence for the existence of a distinct class of sites of action. Journal of Molecular Neuroscience : Mn. 35: 355-61. PMID 18418734 DOI: 10.1007/s12031-008-9062-x  0.68
2008 Alquicer G, Morales-Medina JC, Quirion R, Flores G. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. Journal of Chemical Neuroanatomy. 35: 179-87. PMID 18061401 DOI: 10.1016/j.jchemneu.2007.10.001  1
2007 Dumont Y, Moyse E, Fournier A, Quirion R. Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. Journal of Molecular Neuroscience : Mn. 33: 294-304. PMID 17952639 DOI: 10.1007/s12031-007-9007-9  0.56
2007 Vercauteren FG, Flores G, Ma W, Chabot JG, Geenen L, Clerens S, Fazel A, Bergeron JJ, Srivastava LK, Arckens L, Quirion R. An organelle proteomic method to study neurotransmission-related proteins, applied to a neurodevelopmental model of schizophrenia. Proteomics. 7: 3569-79. PMID 17907268 DOI: 10.1002/pmic.200700379  1
2007 Mechawar N, Lacoste B, Yu WF, Srivastava LK, Quirion R. Developmental profile of neuregulin receptor ErbB4 in postnatal rat cerebral cortex and hippocampus. Neuroscience. 148: 126-39. PMID 17630218 DOI: 10.1016/j.neuroscience.2007.04.066  1
2007 Brouillette J, Young D, During MJ, Quirion R. Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABA(B) receptors in scopolamine-induced amnesia. Journal of Neurochemistry. 102: 1978-89. PMID 17540011 DOI: 10.1111/j.1471-4159.2007.04666.x  1
2007 Bastianetto S, Brouillette J, Quirion R. Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochemical Research. 32: 1720-5. PMID 17406978 DOI: 10.1007/s11064-007-9333-x  0.36
2007 Krantic S, Mechawar N, Reix S, Quirion R. Apoptosis-inducing factor: a matter of neuron life and death. Progress in Neurobiology. 81: 179-96. PMID 17267093 DOI: 10.1016/j.pneurobio.2006.12.002  0.68
2007 Reix S, Mechawar N, Susin SA, Quirion R, Krantic S. Expression of cortical and hippocampal apoptosis-inducing factor (AIF) in aging and Alzheimer's disease. Neurobiology of Aging. 28: 351-6. PMID 16504343 DOI: 10.1016/j.neurobiolaging.2006.01.003  0.68
2006 Ma W, Chabot JG, Quirion R. A role for adrenomedullin as a pain-related peptide in the rat. Proceedings of the National Academy of Sciences of the United States of America. 103: 16027-32. PMID 17043245 DOI: 10.1073/pnas.0602488103  0.68
2006 Trang T, Ma W, Chabot JG, Quirion R, Jhamandas K. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence. Pain. 126: 256-71. PMID 16935424 DOI: 10.1016/j.pain.2006.07.008  0.68
2006 Rowe WB, Kar S, Meaney MJ, Quirion R. Neurotensin receptor levels as a function of brain aging and cognitive performance in the Morris water maze task in the rat. Peptides. 27: 2415-23. PMID 16872718 DOI: 10.1016/j.peptides.2006.03.036  1
2006 Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse (New York, N.Y.). 60: 319-46. PMID 16786561 DOI: 10.1002/syn.20303  1
2006 Takhshid MA, Poyner DR, Chabot JG, Fournier A, Ma W, Zheng WH, Owji AA, Quirion R. Characterization and effects on cAMP accumulation of adrenomedullin and calcitonin gene-related peptide (CGRP) receptors in dissociated rat spinal cord cell culture. British Journal of Pharmacology. 148: 459-68. PMID 16702994 DOI: 10.1038/sj.bjp.0706750  0.68
2006 Carvajal C, Dumont Y, Herzog H, Quirion R. Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice. Journal of Molecular Neuroscience : Mn. 28: 239-45. PMID 16691011 DOI: 10.1385/JMN:28:3:239  0.56
2006 Carvajal C, Dumont Y, Quirion R. Neuropeptide y: role in emotion and alcohol dependence. Cns & Neurological Disorders Drug Targets. 5: 181-95. PMID 16611091  0.56
2006 Han YS, Bastianetto S, Dumont Y, Quirion R. Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 318: 238-45. PMID 16574779 DOI: 10.1124/jpet.106.102319  0.56
2006 Bastianetto S, Danik M, Mennicken F, Williams S, Quirion R. Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation. Bmc Neuroscience. 7: 28. PMID 16573831 DOI: 10.1186/1471-2202-7-28  0.4
2006 Cassidy CM, Quirion R, Srivastava LK. Blockade of presynaptic voltage-gated calcium channels in the medial prefrontal cortex of neonatal rats leads to post-pubertal alterations in locomotor behavior. Brain Research. 1083: 164-73. PMID 16546143 DOI: 10.1016/j.brainres.2006.01.118  1
2006 Bastianetto S, Yao ZX, Papadopoulos V, Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. The European Journal of Neuroscience. 23: 55-64. PMID 16420415 DOI: 10.1111/j.1460-9568.2005.04532.x  0.36
2006 Kar S, Poirier J, Guevara J, Dea D, Hawkes C, Robitaille Y, Quirion R. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Neurobiology of Aging. 27: 199-210. PMID 16399207 DOI: 10.1016/j.neurobiolaging.2005.03.005  1
2006 Dumont Y, Quirion R. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization. Exs. 7-33. PMID 16382995  0.56
2005 Illes J, Blakemore C, Hansson MG, Hensch TK, Leshner A, Maestre G, Magistretti P, Quirion R, Strata P. International perspectives on engaging the public in neuroethics. Nature Reviews. Neuroscience. 6: 977-82. PMID 16340957 DOI: 10.1038/nrn1808  1
2005 Insel TR, Quirion R. Psychiatry as a clinical neuroscience discipline. Jama. 294: 2221-4. PMID 16264165 DOI: 10.1001/jama.294.17.2221  1
2005 Gan L, Han Y, Bastianetto S, Dumont Y, Unterman TG, Quirion R. FoxO-dependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. Biochemical and Biophysical Research Communications. 337: 1092-6. PMID 16236254 DOI: 10.1016/j.bbrc.2005.09.169  0.56
2005 Dumont Y, Gaudreau P, Mazzuferi M, Langlois D, Chabot JG, Fournier A, Simonato M, Quirion R. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes. British Journal of Pharmacology. 146: 1069-81. PMID 16231000 DOI: 10.1038/sj.bjp.0706425  0.68
2005 Krantic S, Mechawar N, Reix S, Quirion R. Molecular basis of programmed cell death involved in neurodegeneration. Trends in Neurosciences. 28: 670-6. PMID 16216345 DOI: 10.1016/j.tins.2005.09.011  0.68
2005 Mogil JS, Miermeister F, Seifert F, Strasburg K, Zimmermann K, Reinold H, Austin JS, Bernardini N, Chesler EJ, Hofmann HA, Hordo C, Messlinger K, Nemmani KV, Rankin AL, Ritchie J, ... ... Quirion R, et al. Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proceedings of the National Academy of Sciences of the United States of America. 102: 12938-43. PMID 16118273 DOI: 10.1073/pnas.0503264102  1
2005 Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides. 26: 1394-400. PMID 16042979 DOI: 10.1016/j.peptides.2005.03.029  1
2005 Dumont Y, Moyse E, Fournier A, Quirion R. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 315: 99-108. PMID 15947033 DOI: 10.1124/jpet.105.089300  0.56
2005 Gan L, Zheng W, Chabot JG, Unterman TG, Quirion R. Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. Journal of Neurochemistry. 93: 1209-19. PMID 15934941 DOI: 10.1111/j.1471-4159.2005.03108.x  0.68
2005 Flores G, Alquicer G, Silva-Gómez AB, Zaldivar G, Stewart J, Quirion R, Srivastava LK. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience. 133: 463-70. PMID 15878241 DOI: 10.1016/j.neuroscience.2005.02.021  1
2005 Flores G, Silva-Gómez AB, Ibáñez O, Quirion R, Srivastava LK. Comparative behavioral changes in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus and the prefrontal cortex. Synapse (New York, N.Y.). 56: 147-53. PMID 15765522 DOI: 10.1002/syn.20140  1
2005 Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, O'dowd BF, George SR, Perreault ML, Männistö PT, Robinson S, et al. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proceedings of the National Academy of Sciences of the United States of America. 102: 3513-8. PMID 15716360 DOI: 10.1073/pnas.0409766102  1
2005 Laplante F, Nakagawasai O, Srivastava LK, Quirion R. Alterations in behavioral responses to a cholinergic agonist in post-pubertal rats with neonatal ventral hippocampal lesions: relationship to changes in muscarinic receptor levels. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1076-87. PMID 15637638 DOI: 10.1038/sj.npp.1300640  0.56
2004 Laplante F, Stevenson CW, Gratton A, Srivastava LK, Quirion R. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex. Journal of Neurochemistry. 91: 1473-82. PMID 15584923 DOI: 10.1111/j.1471-4159.2004.02831.x  1
2004 Bruno MA, Clarke PB, Seltzer A, Quirion R, Burgess K, Cuello AC, Saragovi HU. Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 8009-18. PMID 15371501 DOI: 10.1523/JNEUROSCI.1508-04.2004  1
2004 Dumont Y, Thakur M, Beck-Sickinger A, Fournier A, Quirion R. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP. Neuropeptides. 38: 163-74. PMID 15337369 DOI: 10.1016/j.npep.2004.04.007  0.56
2004 Carvajal CC, Vercauteren F, Dumont Y, Michalkiewicz M, Quirion R. Aged neuropeptide Y transgenic rats are resistant to acute stress but maintain spatial and non-spatial learning. Behavioural Brain Research. 153: 471-80. PMID 15265645 DOI: 10.1016/j.bbr.2004.01.004  0.56
2003 Silva-Gómez AB, Bermudez M, Quirion R, Srivastava LK, Picazo O, Flores G. Comparative behavioral changes between male and female postpubertal rats following neonatal excitotoxic lesions of the ventral hippocampus. Brain Research. 973: 285-92. PMID 12738072 DOI: 10.1016/S0006-8993(03)02537-X  1
2002 Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Progress in Neurobiology. 68: 209-45. PMID 12450488 DOI: 10.1016/S0301-0082(02)00079-5  1
2001 Auld DS, Mennicken F, Quirion R. Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3375-82. PMID 11331367  1
2001 Auld DS, Mennicken F, Day JC, Quirion R. Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons. Journal of Neurochemistry. 77: 253-62. PMID 11279281 DOI: 10.1046/j.1471-4159.2001.00234.x  1
2000 Webster HH, Flores G, Marcotte ER, Cecyre D, Quirion R, Srivastava LK. Olfactory bulbectomy alters NMDA receptor levels in the rat prefrontal cortex. Synapse (New York, N.Y.). 37: 159-62. PMID 10881036 DOI: 10.1002/1098-2396(200008)37:2<159::AID-SYN9>3.0.CO;2-N  1
2000 St-Pierre JA, Nouel D, Dumont Y, Beaudet A, Quirion R. Association of neuropeptide Y Y1 receptors with glutamate-positive and NPY-positive neurons in rat hippocampal cultures. The European Journal of Neuroscience. 12: 1319-30. PMID 10762361 DOI: 10.1046/j.1460-9568.2000.00024.x  1
2000 St-Pierre JA, Nouel D, Dumont Y, Beaudet A, Quirion R. Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y Y(1) receptors. Glia. 30: 82-91. PMID 10696147 DOI: 10.1002/(SICI)1098-1136(200003)30:1<82::AID-GLIA9>3.0.CO;2-8  1
2000 Auld DS, Day JC, Mennicken F, Quirion R. Pharmacological characterization of endogenous acetylcholine release from primary septal cultures. The Journal of Pharmacology and Experimental Therapeutics. 292: 692-7. PMID 10640307  1
1999 Redrobe JP, Dumont Y, St-Pierre JA, Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Research. 848: 153-66. PMID 10612707  0.56
1999 Flores G, Liang JJ, Sierra A, Martínez-Fong D, Quirion R, Aceves J, Srivastava LK. Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography. Neuroscience. 91: 549-56. PMID 10366012 DOI: 10.1016/S0306-4522(98)00633-2  1
1998 Flores G, Wood GK, Barbeau D, Quirion R, Srivastava LK. Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Research. 814: 34-40. PMID 9838033 DOI: 10.1016/S0006-8993(98)01011-7  1
1998 Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. Journal of Neurochemistry. 70: 2179-87. PMID 9572306  1
1998 St-Pierre JA, Dumont Y, Nouel D, Herzog H, Hamel E, Quirion R. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor. British Journal of Pharmacology. 123: 183-94. PMID 9489605 DOI: 10.1038/sj.bjp.0701589  0.56
1998 Auld DS, Kar S, Quirion R. Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link? Trends in Neurosciences. 21: 43-9. PMID 9464686 DOI: 10.1016/S0166-2236(97)01144-2  1
1997 Wood GK, Liang JJ, Flores G, Ahmad S, Quirion R, Srivastava LK. Cloning and in situ hybridization analysis of the expression of polysialyltransferase mRNA in the developing and adult rat brain. Brain Research. Molecular Brain Research. 51: 69-81. PMID 9427508 DOI: 10.1016/S0169-328X(97)00209-X  1
1997 Nouel D, Faure MP, St Pierre JA, Alonso R, Quirion R, Beaudet A. Differential binding profile and internalization process of neurotensin via neuronal and glial receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1795-803. PMID 9030638  1
1996 Flores G, Wood GK, Liang JJ, Quirion R, Srivastava LK. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 7366-75. PMID 8929443  1
1996 Le Jeune H, Aubert I, Jourdan F, Quirion R. Developmental profiles of various cholinergic markers in the rat main olfactory bulb using quantitative autoradiography. The Journal of Comparative Neurology. 373: 433-50. PMID 8889937 DOI: 10.1002/(SICI)1096-9861(19960923)373:3<433::AID-CNE8>3.0.CO;2-3  1
1996 Dumont Y, St-Pierre JA, Quirion R. Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport. 7: 901-4. PMID 8724669  0.56
1996 Aubert I, Cécyre D, Gauthier S, Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. The Journal of Comparative Neurology. 369: 31-55. PMID 8723701 DOI: 10.1002/(SICI)1096-9861(19960520)369:1<31::AID-CNE3>3.0.CO;2-L  1
1996 Flores G, Barbeau D, Quirion R, Srivastava LK. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 2020-6. PMID 8604046  1
1995 Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 92: 12260-4. PMID 8618881 DOI: 10.1073/pnas.92.26.12260  1
1995 Le Jeune H, Aubert I, Jourdan F, Quirion R. Comparative laminar distribution of various autoradiographic cholinergic markers in adult rat main olfactory bulb. Journal of Chemical Neuroanatomy. 9: 99-112. PMID 8561953 DOI: 10.1016/0891-0618(95)00070-N  1
1995 Parent A, Rowe W, Meaney MJ, Quirion R. Increased production of inositol phosphates and diacylglycerol in aged cognitively impaired rats after stimulation of muscarinic, metabotropic-glutamate and endothelin receptors. The Journal of Pharmacology and Experimental Therapeutics. 272: 1110-6. PMID 7891323  1
1995 Quirion R, Wilson A, Rowe W, Aubert I, Richard J, Doods H, Parent A, White N, Meaney MJ. Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 1455-62. PMID 7869110  1
1995 Yashpal K, Pitcher GM, Parent A, Quirion R, Coderre TJ. Noxious thermal and chemical stimulation induce increases in 3H-phorbol 12,13-dibutyrate binding in spinal cord dorsal horn as well as persistent pain and hyperalgesia, which is reduced by inhibition of protein kinase C. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 3263-72. PMID 7751909  1
1995 Aubert I, Rowe W, Meaney MJ, Gauthier S, Quirion R. Cholinergic markers in aged cognitively impaired Long-Evans rats. Neuroscience. 67: 277-92. PMID 7675169 DOI: 10.1016/0306-4522(95)00056-O  1
1995 Krieger C, Jacques D, Parent A, Quirion R. [3H]phorbol 12,13-dibutyrate/PKC binding in thoracic spinal cord: no change in amyotrophic lateral sclerosis. Neuroreport. 6: 1381-4. PMID 7488729  1
1994 Aubert I, Poirier J, Gauthier S, Quirion R. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2476-84. PMID 8182423  1
1994 Parent A, Quirion R. Differential localization and pH dependency of phosphoinositide 1,4,5-IP3, 1,3,4,5-IP4 and IP6 receptors in rat and human brains. The European Journal of Neuroscience. 6: 67-74. PMID 8130933 DOI: 10.1111/j.1460-9568.1994.tb00248.x  1
1994 Kar S, Quirion R, Parent A. An interaction between inositol hexakisphosphate (IP6) and insulin-like growth factor II receptor binding sites in the rat brain. Neuroreport. 5: 625-8. PMID 8025258  1
1994 Parent A, Poirier J, Baccichet A, Quirion R. Regulation of 1,4,5-IP3, 1,3,4,5-IP4 and IP6 binding sites following entorhinal cortex lesions in rat brain. Neuroscience. 61: 565-73. PMID 7969930 DOI: 10.1016/0306-4522(94)90434-0  1
1994 Chaudieu I, St-Pierre JA, Quirion R, Boksa P. GABAA receptor-mediated inhibition of N-methyl-D-aspartate-evoked [3H]dopamine release from mesencephalic cell cultures. European Journal of Pharmacology. 264: 361-9. PMID 7698177 DOI: 10.1016/0014-2999(94)00492-7  1
1993 Parent A, Dea D, Quirion R, Poirier J. [3H]phorbol ester binding sites and neuronal plasticity in the hippocampus following entorhinal cortex lesions. Brain Research. 607: 23-32. PMID 8481798 DOI: 10.1016/0006-8993(93)91485-B  1
1993 Quirion R, Aubert I, Araujo DM, Hersi A, Gaudreau P. Autoradiographic distribution of putative muscarinic receptor sub-types in mammalian brain. Progress in Brain Research. 98: 85-93. PMID 8248541  1
1992 Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. Journal of Neurochemistry. 58: 529-41. PMID 1729398  1
1992 Aubert I, Cécyre D, Gauthier S, Quirion R. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain. European Journal of Pharmacology. 217: 173-84. PMID 1425938 DOI: 10.1016/0014-2999(92)90843-S  1
1990 Quirion R, Aubert I, Robitaille Y, Gauthier S, Araujo DM, Chabot JG. Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies. Clinical Neuropharmacology. 13: S73-80. PMID 2093419  1
1989 Quirion R, Aubert I, Lapchak PA, Schaum RP, Teolis S, Gauthier S, Araujo DM. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. Trends in Pharmacological Sciences. 80-4. PMID 2694529  1
1987 Gaudreau P, St-Pierre S, Pert CB, Quirion R. Structure-activity studies of C- and N-terminal fragments of cholecystokinin 26-33 in guinea pig isolated tissues. Neuropeptides. 10: 9-18. PMID 3670570 DOI: 10.1016/0143-4179(87)90084-9  1
1985 Gaudreau P, St-Pierre S, Pert CB, Quirion R. Cholecystokinin receptors in mammalian brain. A comparative characterization and visualization. Annals of the New York Academy of Sciences. 448: 198-219. PMID 2992345 DOI: 10.1111/j.1749-6632.1985.tb29919.x  1
1984 Quirion R, DiMaggio DA, French ED, Contreras PC, Shiloach J, Pert CB, Everist H, Pert A, O'Donohue TL. Evidence for an endogenous peptide ligand for the phencyclidine receptor. Peptides. 5: 967-73. PMID 6095223 DOI: 10.1016/0196-9781(84)90124-4  1
1984 Finkel MS, Quirion R, Pert C, Patterson RE. Characterization and autoradiographic distribution of the beta-adrenergic receptor in the rat lung. Pharmacology. 29: 247-54. PMID 6093158  1
1983 Quirion R, Pert CB. Properties of the phencyclidine (PCP) receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 7: 451-6. PMID 6320296 DOI: 10.1016/0278-5846(83)90010-6  1
1983 Gaudreau P, Quirion R, St-Pierre S, Pert CB. Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin. Peptides. 4: 755-62. PMID 6318206 DOI: 10.1016/0196-9781(83)90032-3  1
1983 Rice KC, Konicki PE, Quirion R, Burke TR, Pert CB. Synthesis and pharmacological characterization of (+/-)-5,9 alpha-dimethyl-2-[2-(4-fluorophenyl)ethyl]-2'-hydroxy-6,7-benzomorphan (fluorophen), a ligand suitable for visualization of opiate receptors in vivo. Journal of Medicinal Chemistry. 26: 1643-5. PMID 6313921  1
1983 Quirion R, Pert CB. Modulation of phencyclidine receptor sensitivity. Nida Research Monograph. 43: 217-23. PMID 6308454  1
1983 Gaudreau P, Quirion R, St-Pierre S, Pert CB. Tritium-sensitive film autoradiography of [3H]cholecystokinin-5/pentagastrin receptors in rat brain. European Journal of Pharmacology. 87: 173-4. PMID 6301853 DOI: 10.1016/0014-2999(83)90071-7  1
1983 Altura BT, Quirion R, Pert CB, Altura BM. Phencyclidine ("angel dust") analogs and sigma opiate benzomorphans cause cerebral arterial spasm. Proceedings of the National Academy of Sciences of the United States of America. 80: 865-9. PMID 6298779  1
1983 Quirion R, Shults CW, Moody TW, Pert CB, Chase TN, O'Donohue TL. Autoradiographic distribution of substance P receptors in rat central nervous system. Nature. 303: 714-6. PMID 6190094 DOI: 10.1038/303714a0  1
1983 Quirion R, Weiss AS, Pert CB. Comparative pharmacological properties and autoradiographic distribution of [3H]ethylketocyclazocine binding sites in rat and guinea pig brain. Life Sciences. 33: 183-6. PMID 6141485 DOI: 10.1016/0024-3205(83)90473-3  1
1982 Quirion R, Pert CB. Certain calcium antagonists are potent displacers of [3H]phencyclidine (PCP) binding in rat brain. European Journal of Pharmacology. 83: 155-6. PMID 7128698 DOI: 10.1016/0014-2999(82)90305-3  1
1982 Quirion R, Bowen WD, Herkenham M, Pert CB. Visualization and solubilization of rat brain opiate receptors with a "kappa" ligand selectivity pattern. Cellular and Molecular Neurobiology. 2: 333-46. PMID 6305502 DOI: 10.1007/BF00710853  1
1982 Olgiati V, Quirion R, Bowen WD, Pert CB. Characterization of type 2 opiate receptors. Life Sciences. 31: 1675-8. PMID 6296570 DOI: 10.1016/0024-3205(82)90183-7  1
1982 Quirion R, Bayorh MA, Zerbe RL, Pert CB. Chronic phencyclidine treatment decreases phencyclidine and dopamine receptors in rat brain. Pharmacology, Biochemistry, and Behavior. 17: 699-702. PMID 6294678 DOI: 10.1016/0091-3057(82)90349-5  1
1982 Quirion R, Gaudreau P, St-Pierre S, Rioux F, Pert CB. Autoradiographic distribution of [3H]neurotensin receptors in rat brain: visualization by tritium-sensitive film. Peptides. 3: 757-63. PMID 6294631 DOI: 10.1016/0196-9781(82)90011-0  1
1982 Quirion R, Hammer RP, Herkenham M, Pert CB. Autoradiographic localization of the phencyclidine/sigma "opiate" receptor in rat brain. Nida Research Monograph. 41: 178-83. PMID 6289117  1
1982 Quirion R, Kiso Y, Pert CB. Syndyphalin SD-25: a highly selective ligand for mu opiate receptors. Febs Letters. 141: 203-6. PMID 6284554 DOI: 10.1016/0014-5793(82)80047-1  1
1982 Hammer RP, Herkenham M, Pert CB, Quirion R. Correlation of regional brain metabolism with receptor localization during ketamine anesthesia: combined autoradiographic 2-[3H]deoxy-D-glucose receptor binding technique. Proceedings of the National Academy of Sciences of the United States of America. 79: 3067-70. PMID 6283555  1
1982 Quirion R, Pert CB. Amantadine modulates phencyclidine binding site sensitivity in rat brain. Experientia. 38: 955-6. PMID 6215256 DOI: 10.1007/BF01953674  1
1981 Quirion R, Rice KC, Skolnick P, Paul S, Pert CB. Stereospecific displacement of [3H]phencyclidine (PCP) receptor binding by an enantiomeric pair of PCP analogs. European Journal of Pharmacology. 74: 107-8. PMID 6459238 DOI: 10.1016/0014-2999(81)90330-7  1
1981 Quirion R, Hammer RP, Herkenham M, Pert CB. Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proceedings of the National Academy of Sciences of the United States of America. 78: 5881-5. PMID 6272322  1
1981 Quirion R, Pert CB. Dynorphins: similar relative potencies on mu, delta- and kappa-opiate receptors. European Journal of Pharmacology. 76: 467-8. PMID 6120085 DOI: 10.1016/0014-2999(81)90125-4  1
Show low-probability matches.